Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.6.4 was added, replacing the previous Revision: v3.6.3 in the page's study record dates.SummaryDifference0.0%

- Check21 days agoChange DetectedNo changes were recorded for this page. The study overview, design, and eligibility criteria remain as published.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe study record revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. The change reflects an incremental update to the publicly posted record rather than substantive content changes.SummaryDifference0.0%

- Check42 days agoChange DetectedSite revision updated from v3.6.0 to v3.6.2, reflecting a backend platform update on the study page. No study details or navigation are affected.SummaryDifference0.0%

- Check56 days agoChange DetectedDifference0.4%

- Check64 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the page's build or content management system. This update does not modify the study details, eligibility criteria, or results presented on the page.SummaryDifference0.0%

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.